{"id":"https://openalex.org/W4415312229","doi":"https://doi.org/10.59556/japi.73.1172","title":"Prediabetes: To Be Treated or Not?","display_name":"Prediabetes: To Be Treated or Not?","publication_year":2025,"publication_date":"2025-10-01","ids":{"openalex":"https://openalex.org/W4415312229","doi":"https://doi.org/10.59556/japi.73.1172","pmid":"https://pubmed.ncbi.nlm.nih.gov/41100339"},"language":"en","primary_location":{"id":"pmid:41100339","doi":"https://doi.org/10.59556/japi.73.1172","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41100339","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of the Association of Physicians of India","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102915245","display_name":"R.P. Agrawal","orcid":"https://orcid.org/0009-0007-1237-210X","observed_orcids":["https://orcid.org/0009-0007-1237-210X"]},"institutions":[{"id":"https://openalex.org/I4405269273","display_name":"Research Society for the Study of Diabetes in India","ror":"https://ror.org/03mkn1k40","country_code":"IN","type":"nonprofit","lineage":["https://openalex.org/I4405269273"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Rajesh Agrawal","raw_affiliation_strings":["Secretary, RSSDI, Madhya Pradesh; CEO, Department of Medicine, Diabetes Overweight Thyroid and Hormone Clinic, Indore, Madhya Pradesh, India, Corresponding Author, Orcid: https://orcid.org/0009-0007-1237-210X"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Secretary, RSSDI, Madhya Pradesh; CEO, Department of Medicine, Diabetes Overweight Thyroid and Hormone Clinic, Indore, Madhya Pradesh, India, Corresponding Author, Orcid: https://orcid.org/0009-0007-1237-210X","institution_ids":["https://openalex.org/I4405269273"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5102915245"],"corresponding_institution_ids":["https://openalex.org/I4405269273"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"10","first_page":"96","last_page":"98"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8398000001907349,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8398000001907349,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.09669999778270721,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.04769999906420708,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prediabetes","display_name":"prediabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes-prevention","display_name":"type 2 diabetes prevention","score":0.9750000238418579},{"id":"https://openalex.org/keywords/impaired-fasting-glucose","display_name":"impaired fasting glucose","score":0.843999981880188},{"id":"https://openalex.org/keywords/impaired-glucose-tolerance","display_name":"impaired glucose tolerance","score":1.0},{"id":"https://openalex.org/keywords/progression-to-diabetes","display_name":"progression to diabetes","score":0.6200000047683716},{"id":"https://openalex.org/keywords/lifestyle-intervention","display_name":"lifestyle intervention","score":0.7829999923706055},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.8360000252723694},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9750000238418579},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.8600000143051147},{"id":"https://openalex.org/keywords/alpha-glucosidase-inhibitors","display_name":"alpha-glucosidase inhibitors","score":0.9549999833106995},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9169999957084656},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9959999918937683},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9980000257492065},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9539999961853027},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.8140000104904175},{"id":"https://openalex.org/keywords/microvascular-complications","display_name":"microvascular complications","score":0.6370000243186951},{"id":"https://openalex.org/keywords/prevalence-projections","display_name":"prevalence projections","score":0.30399999022483826}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9143999814987183},{"id":"https://openalex.org/C2779668308","wikidata":"https://www.wikidata.org/wiki/Q2087205","display_name":"Prediabetes","level":4,"score":0.9106000065803528},{"id":"https://openalex.org/C2777185836","wikidata":"https://www.wikidata.org/wiki/Q3306264","display_name":"Impaired fasting glucose","level":5,"score":0.7099000215530396},{"id":"https://openalex.org/C2780609358","wikidata":"https://www.wikidata.org/wiki/Q2087205","display_name":"Impaired glucose tolerance","level":4,"score":0.5878000259399414},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5716999769210815},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.5547999739646912},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5123000144958496},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.3603000044822693},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.35839998722076416},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.352400004863739},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.3441999852657318},{"id":"https://openalex.org/C2778848681","wikidata":"https://www.wikidata.org/wiki/Q6725716","display_name":"Macrovascular disease","level":4,"score":0.33500000834465027},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.3147999942302704},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3003000020980835},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.2782000005245209},{"id":"https://openalex.org/C2780665704","wikidata":"https://www.wikidata.org/wiki/Q959298","display_name":"Intervention (counseling)","level":2,"score":0.27619999647140503},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.26910001039505005}],"mesh":[{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011236","descriptor_name":"Prediabetic State","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D011236","descriptor_name":"Prediabetic State","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011236","descriptor_name":"Prediabetic State","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D011236","descriptor_name":"Prediabetic State","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:41100339","doi":"https://doi.org/10.59556/japi.73.1172","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41100339","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of the Association of Physicians of India","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7124249987","https://openalex.org/W2342072646","https://openalex.org/W2166918837","https://openalex.org/W2042140365","https://openalex.org/W4415366612","https://openalex.org/W2913745357","https://openalex.org/W2106405861","https://openalex.org/W4250185040","https://openalex.org/W2116128857","https://openalex.org/W2767475547"],"abstract_inverted_index":{"Prediabetes":[0],"(PD)":[1],"is":[2,31,90,119,149,315,338,350,356,436,461,496,581],"a":[3,62,160,368,455,526,571],"bridge":[4],"between":[5],"normoglycemia":[6],"and":[7,68,71,80,132,137,144,168,176,183,188,223,247,260,284,336,353,399,442,501,507,517,529,554,568,570,600,605,607],"hyperglycemia":[8],"or":[9,193,215,384,440,493,576],"diabetes":[10],"mellitus":[11],"(DM)":[12],"characterized":[13],"by":[14,33,212,238,326],"higher":[15],"than":[16,331,486],"normal":[17],"blood":[18,566],"glucose":[19,36,39,263,567],"but":[20,48,328],"not":[21,405,424],"fulfilling":[22],"the":[23,135,232,407,445,449,463,469,487,538,590],"criteria":[24,465,481],"for":[25,208,318,341,390,448,466,482],"type":[26],"2":[27,281],"DM":[28,310,321,488],"(T2DM).":[29],"PD":[30,52,148,152,158,196,211,235,251,325,423,483,506,549],"defined":[32],"impaired":[34,38,257],"fasting":[35],"(IFG),":[37],"tolerance":[40],"(IGT),":[41],"and/or":[42],"hemoglobin":[43],"A1c":[44],"(HbA1c)":[45],"above":[46,408,462],"5.7%":[47],"<6.4%.":[49],"Individuals":[50,156],"with":[51,140,157,171,267,312,324,510,525],"are":[53,169,205,294,363,473,484,534,561,587],"at":[54,61,364,415,418,556],"increased":[55,172,261,515],"risk":[56,163,173,409,573],"of":[57,64,78,101,164,174,195,210,234,320,348,372,375,438,451,458,491,499,540,574],"progressing":[58,165],"to":[59,92,94,109,111,127,130,133,153,166,197,230,236,244,254,425,434,514,536,547,563,578,583],"T2DM":[60,131,167,237,298],"pace":[63],"5-10%":[65,161],"every":[66,420],"year":[67],"other":[69,330],"micro-":[70,175],"macrovascular":[72,177],"complications,":[73,143],"including":[74],"cardiovascular":[75,184,249],"diseases.":[76],"Prevalence":[77],"IGT":[79],"IFG":[81,102],"in":[82,98,115,296,299,309,322,344,476,589],"2021":[83],"was":[84,103],"9.1%":[85],"(about":[86,105],"464":[87],"million),":[88,107],"which":[89,460],"projected":[91,108],"increase":[93,110],"10.0%":[95],"(638":[96],"million)":[97,114],"2045;":[99],"that":[100,360,544],"5.8%":[104],"298":[106],"6.5%":[112],"(414":[113],"2045":[116],"globally.":[117],"That":[118],"why":[120],"we":[121,199,429,474],"must":[122,200,387,550],"seriously":[123],"take":[124],"aggressive":[125],"steps":[126],"prevent":[128,191],"progression":[129,192,233,575],"reduce":[134,231],"morbidity":[136],"mortality":[138],"associated":[139,170,385,524,594],"DM,":[141,198,373,431,579],"its":[142,530],"healthcare":[145,518],"burden.":[146],"Why":[147,151,422],"important?":[150],"be":[154,201,388,412,426,551,597],"treated?":[155,427],"have":[159,227,333,406,548,564],"annual":[162],"complications":[178],"like":[179,379,393,444],"nephropathy,":[180],"retinopathy,":[181],"neuropathy,":[182],"risks,":[185],"myocardial":[186],"infarction,":[187],"stroke.":[189],"To":[190],"conversion":[194,577],"very":[202],"aggressive.":[203],"These":[204,240],"sufficient":[206],"reasons":[207],"treatment":[209,489],"lifestyle":[213,219,602],"intervention":[214],"pharmacotherapy,":[216,327],"as":[217,479,505,520,522],"intensive":[218],"modifications,":[220],"dietary":[221],"modification,":[222],"enhanced":[224],"physical":[225],"activity":[226],"been":[228],"shown":[229,306],"40-70%.":[239],"measures":[241],"also":[242],"lead":[243,513],"weight":[245,608],"loss":[246],"better":[248],"health.":[250],"develops":[252],"due":[253],"insulin":[255,258,377],"resistance,":[256],"secretion,":[259],"hepatic":[262],"production.":[264],"Therefore,":[265],"pharmacotherapy":[266,349,392,511],"metformin,":[268],"pioglitazone,":[269],"\u03b1-glucosidase":[270],"inhibitors":[271],"(AGIs),":[272],"dipeptidyl":[273],"peptidase":[274],"IV":[275,397],"(DPP":[276],"IV)":[277],"inhibitors,":[278,283,395,398],"sodium-glucose":[279],"cotransporter":[280],"(SGLT2)":[282],"glucagon-like":[285],"peptide-1":[286],"receptor":[287],"agonists":[288],"(GLP1":[289],"RA)":[290],"targeting":[291],"these":[292],"defects":[293],"efficacious":[295],"preventing":[297],"PD.":[300,345,467],"Diabetes":[301,452],"Prevention":[302],"Program":[303],"(DPP)":[304],"has":[305],"31%":[307],"reduction":[308],"incidence":[311],"metformin.":[313],"There":[314,495],"increasing":[316],"evidence":[317],"prevention":[319],"adults":[323],"options":[329],"metformin":[332],"adverse":[334],"effects,":[335],"there":[337],"no":[339,354],"unanimity":[340],"their":[342],"use":[343],"The":[346],"role":[347],"still":[351],"debatable,":[352],"consensus":[355],"made.":[357],"We":[358,542],"recommend":[359,454],"patients":[361],"who":[362,403,586],"high":[365,572],"risk,":[366],"having":[367],"strong":[369],"family":[370],"history":[371],"signs":[374],"severe":[376,382],"resistance":[378],"acanthosis":[380],"nigricans,":[381],"obesity,":[383],"comorbidities,":[386],"considered":[389],"disease-modifying":[391],"SGLT2":[394],"DPP":[396],"GLP1":[400],"RA.":[401],"Those":[402,585],"do":[404],"factors":[410],"should":[411,596],"followed":[413],"up":[414],"regular":[416,557],"intervals,":[417],"least":[419],"year.":[421],"When":[428],"treat":[430],"our":[432],"\"treat":[433],"target\"":[435],"HbA1c":[437,569],"7%":[439,492],"less,":[441],"organizations":[443],"European":[446],"Association":[447],"Study":[450],"(EASD)":[453],"stricter":[456],"target":[457,490],"6.5%,":[459],"diagnostic":[464,480],"Then":[468],"million-dollar":[470],"question":[471],"arises:":[472],"justified":[475],"treating":[477,508],"PD,":[478],"lower":[485],"less?":[494],"another":[497],"issue":[498],"overdiagnosis":[500],"overmedication;":[502],"labeling":[503],"individuals":[504],"them":[509],"may":[512],"medication":[516],"costs,":[519],"well":[521],"stigma":[523],"chronic":[527],"disease":[528],"treatment.":[531],"Long-term":[532],"studies":[533],"required":[535],"evaluate":[537],"risk-benefit":[539],"pharmacotherapy.":[541],"suggest":[543],"persons":[545],"identified":[546],"under":[552],"vigilance":[553],"investigated":[555],"intervals.":[558],"If":[559],"they":[560],"found":[562],"incremental":[565],"it":[580],"logical":[582],"treat.":[584],"stable":[588],"prediabetic":[591],"range":[592],"without":[593],"comorbidities":[595],"observed":[598],"regularly":[599],"advised":[601],"modification":[603],"(diet":[604],"exercise)":[606],"reduction.":[609]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2025-10-18T00:00:00"}